Advancements in Vaccines: Bridging the Past and Future – by Nelia Sanchez-Crespo, MD

The history of vaccines is a testament to the incredible progress we’ve made in protecting humanity against infectious diseases. From the invention of the smallpox vaccine by Edward Jenner in the late 18th century to the contemporary vaccines we rely on today, these medical marvels have played a pivotal role in safeguarding public health. As we move closer to 2024, it’s worth exploring how vaccines have evolved and how modern vaccines differ from their historical counterparts.


The Foundation of Vaccines

Vaccines, in their simplest form, work by stimulating the immune system to recognize and defend against specific pathogens, such as viruses or bacteria. Early vaccines, like the smallpox vaccine, primarily used weakened or inactivated forms of the pathogen to trigger an immune response without causing the disease itself. This concept laid the foundation for vaccine development.


Modern Vaccine Advancements

Fast forward to the present, and vaccines have come a long way. Here are some key advancements that distinguish vaccines in 2023 from those developed long ago:


1. Targeted Precision: Modern vaccines are highly specific. They can target a particular strain or variant of a pathogen, increasing their effectiveness.


2. mRNA Technology: Perhaps the most notable advancement is the development of mRNA vaccines like the COVID-19 vaccines. Instead of using weakened pathogens, these vaccines provide genetic instructions to our cells to produce a harmless piece of the pathogen, prompting an immune response. This breakthrough technology allows for faster vaccine development.


3. Adjuvants: Adjuvants are substances added to vaccines to enhance the body’s immune response. Modern vaccines often include adjuvants that make the vaccine more effective with smaller doses.


4. Vaccine Platforms: Scientists have developed various vaccine platforms, each with its unique approach. These platforms provide flexibility in designing vaccines for different diseases.


5. Enhanced Safety Measures: Rigorous safety testing is a cornerstone of modern vaccine development. Stringent regulations and monitoring systems ensure that vaccines are safe and effective.


6. Global Collaboration: Today, international collaboration and data-sharing expedite vaccine development. The global response to the COVID-19 pandemic exemplifies this cooperative approach.


7. Personalized Vaccines: Some experimental vaccines are exploring personalized medicine, tailoring vaccines to an individual’s genetic makeup and specific health needs.


Vaccine Hesitancy and Education

While the advancements in vaccine technology are remarkable, the importance of vaccine education and addressing vaccine hesitancy cannot be overstated. With the proliferation of information, it’s essential to provide clear, evidence-based information about vaccines to combat misinformation.


Protecting Our Future

As we reflect on the evolution of vaccines, it’s clear that science has made tremendous strides in safeguarding global health. The vaccines of 2023 represent the culmination of centuries of research, innovation, and dedication to public health. Looking ahead, the future promises even more exciting developments in the field of vaccinology, ensuring that we continue to protect generations to come against infectious diseases. Together, we can bridge the gap between the past and the future, preserving the health and well-being of humanity.


If you’d like more information on how CenExel may support your vaccine or infectious disease clinical trials, please visit



Nelia Sanchez-Crespo, MD; Principal Investigator

CenExel RCA – 7261 Sheridan Street, Suite 210, Hollywood, FL 33024

Dr. Nelia Sanchez-Crespo is an Internal Medicine Physician graduated Cum Laude from PUCMM in Dominican Republic and completed specialty training in United States at Atlanta Medical Center with high honors. She is Board Certified in Internal Medicine. Dr. Sanchez-Crespo has continued experience through over 15 years of medical practice. She is an investigator in multiple clinical trials at CenExel RCA and she secures patient care through the research operation. She is fluent in English and Spanish.